April 30, 2025
Şirkete Özel
Summary and Outlook
Şirkete Özel
Management Reporting: IFRS Financials excluding inflation accounting effect
Leadership position in both Pension AuM and Life & PA premium production among private companies thanks to significant growth across all channels and product lines.Q1 2025 Performance
#1 position in Private Pension AuM among private companies; 19.5% m.s.
#1 position in Total Life & PA GWP among private companies; 12.5% m.s.
Robust net profit growth both in terms of Management Reporting and SFRS with 60% and 66% yoy increase respectively
1.000 mTL dividend has been paid in Q1
Agesa has become the sole shareholder of Medisa with 100% share as of December 2024. Additional 650 mTL has been paid as capital in January 2025. Total investment amount is reached 1.4 bTL
Share buyback program; 1.736k shares were bought with an average price of 65.58 TL as of March 2025. Ratio of owned share is 0.96%
Strengthened fundamentals
Strong and exclusive bancassurance partnership with Akbank
Accelerated growth with strengthened base of
DSF
More Diversified Product Portfolio with a New
RoP and Savings Products
Continued investments on digital. analytics and customer capabilities
Synergies with Aksigorta both for topline and operational excellence areas
Regulatory appetite for the growth of both pension
and life business supported by incentives
Strong Shareholder Structure that mixes local expertise and international know how
Future
End to end Digital transformation with a particular focus on new technologies and data analytics
Synergy opportunities among Banking and Insurance services in Sabancı Group
Growth & synergy opportunities with Medisa in
health business.
Sustainability at the heart of business to build a better future
•
Future-proof workforce
organization and an advanced
2
Evolution of Our Strong Performance Core Business
CAGR Inf. 21-24: 61%
robust growth with new participants and returns
strong growth in terms of GWP with strong and
Şirkete Özel
Management Reporting: IFRS Financials excluding inflation accounting effect.
Both Agesa Management reporting and SFRS financial figures are shown before Medisa consolidation.
diversified products
increased focus on pension, ~1 million new customers
Pension AuM, Total
(TL bn)
CAGR 21-24:
74%
YoY 1Q25: 52%
GWP, Total
(TL bn)
CAGR 21-24:
92%
YoY 1Q25: 53%
Customer exc. Credit Linked, #
(mn)
CAGR 21-24:
8%
3
Evolution of Our Strong Performance Profitability
Şirkete Özel
Management Reporting: IFRS Financials excluding inflation accounting effect.
Both Agesa Management reporting and SFRS financial figures are shown before Medisa consolidation.
CAGR Inf. 21-24: 61%
robust growth fueled by solid technical
IFRS Net Profit
(Management Reporting, TL mn)
CAGR 21-24: YoY 1Q25:
95% 60%
Local Net Profit
(TL mn)
CAGR 21-24: YoY 1Q25: 86% 66%
4
Evolution of Our Strong Performance
Şirkete Özel
Expense ratio=(G&A)/(Management Reporting Proft Before Tax-G&A) Management Reporting: IFRS Financials excluding inflation accounting effect.
Both Agesa Management reporting and SFRS financial figures are shown before Medisa consolidation.
Operational ProfitabilityCAGR Inf. 21-24: 61%
Technical Profit
(TL mn)
CAGR 21-24:
87%
YoY 1Q25: 80%
G&A, Expense Ratio
(TL mn, %)
CAGR 21-24:
87%
YoY 1Q25: 62%
Net Technical Profit
(TL mn)
CAGR 21-24:
86%
YoY 1Q25: 105%
5